A Current Review of Targeted Therapeutics for Ovarian Cancer
Difficult to detect, ovarian cancer typically presents at an advanced stage. Significant progress has been achieved in the treatment of ovarian cancer with therapeutics focused on DNA replication or cell division. However, despite sensitivity to induction chemotherapy the majority of patients will d...
Main Authors: | Susana M. Campos, Sue Ghosh |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2010-01-01
|
Series: | Journal of Oncology |
Online Access: | http://dx.doi.org/10.1155/2010/149362 |
Similar Items
-
Current Position of the Molecular Therapeutic Targets for Ovarian Clear Cell Carcinoma: A Literature Review
by: Tsukuru Amano, et al.
Published: (2019-07-01) -
Pathogenesis and New Therapeutic Targets of Ovarian Cancer
by: Ie-Ming Shih, et al.
Published: (2012-01-01) -
Therapeutic Targeting of Collective Invasion in Ovarian Cancer
by: Laura Moffitt, et al.
Published: (2019-03-01) -
Purinergic signalling pathway: therapeutic target in ovarian cancer
by: Nisha Chandran, et al.
Published: (2020-06-01) -
An Overview of Candidate Therapeutic Target Genes in Ovarian Cancer
by: Elena Alexandrova, et al.
Published: (2020-06-01)